Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

NCT00509041 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Malignant Mesothelioma

Interventions

DRUG: dasatinib

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]